Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Vyzulta
Vyzulta Image


Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Vyzulta?

Vyzulta (latanoprostene bunod) is a medication prescribed to patients who have open-angle glaucoma or ocular hypertension. Its primary goal is to reduce eye pressure, which is a key factor in the development and progression of these conditions. Latanoprostene bunod is a prostaglandin analog that works by increasing the outflow of fluid from the eye, thereby reducing intraocular pressure. Lowering eye pressure is crucial in managing glaucoma and ocular hypertension, as it helps to prevent further damage to the optic nerve and preserve vision. Vyzulta is typically administered as eye drops, and the recommended dosage and frequency of use should be followed as prescribed by a healthcare professional. It is important to note that Vyzulta should only be used under medical supervision and as directed, as improper usage may lead to ineffective treatment or potential side effects. Potential side effects of Vyzulta may include eye redness, eye irritation, blurred vision, darkening of the eyelashes, and changes in iris color. If you experience any unusual or severe side effects, it is important to seek medical attention. It is worth noting that Vyzulta may interact with other medications, so it is important to inform your healthcare provider about any other drugs you are taking to avoid potential drug interactions. If you have any concerns or questions about the use of Vyzulta, it is best to consult with a healthcare professional who can provide personalized advice and guidance based on your specific situation.

How to use Vyzulta?

To use Vyzulta, follow these steps: 1. Before applying the medication, wash your hands thoroughly to prevent any infection or contamination. 2. Tilt your head back slightly and pull your lower eyelid down to form a small pocket. 3. Hold the Vyzulta dropper close to your eye, but be careful not to touch it. 4. Squeeze the prescribed number of drops (usually one drop) into the eye. 5. After applying the eye drops, close your eyes gently for about 1-2 minutes. This will ensure that the medication is absorbed properly into the eye. 6. If you are using other eye drops as well, wait at least 5 minutes before applying them. This will prevent any potential interactions between the medications. 7. To prevent contamination, make sure the dropper tip does not touch any surfaces or your eye. Remember to use Vyzulta exactly as prescribed by your doctor. Do not change the dosage or frequency of use without consulting your healthcare provider. If you have any questions or concerns about the proper use of Vyzulta, it is important to reach out to your prescribing physician or a healthcare professional for clarification.

Before using Vyzulta, it's important to be aware of the associated warnings and precautions. Here are a few key ones: 1. Allergic reactions: Some individuals may experience an allergic reaction to Vyzulta, characterized by symptoms like rash, itching, swelling, severe dizziness, or difficulty breathing. Seek immediate medical attention if any signs of an allergic reaction occur. 2. Eye-related concerns: Vyzulta may cause changes in the pigmentation (color) of the iris, eyelashes, and eyelids. It may also lead to increased brown pigmentation of the iris, which is typically permanent. Patients should also be cautious if they have a history of eye conditions like iritis or uveitis, as Vyzulta may exacerbate these conditions. 3. Eye inflammation: Vyzulta can potentially trigger inflammation within the eye, particularly if you have a known history of macular edema. Contact your eye doctor if you experience symptoms such as eye pain, swelling, redness, or blurring of vision. 4. Contact lenses: If you wear contact lenses, it is recommended to remove them before using Vyzulta. You may reinsert them 15 minutes after instillation. 5. Pregnancy and breastfeeding: The safety of Vyzulta during pregnancy and breastfeeding has not been established. Consult with your healthcare provider if you are pregnant, planning to become pregnant, or nursing before using this medication. As with any medication, it's important to closely follow your doctor's instructions, report any side effects promptly, and attend regular check-ups to monitor your eye health and response to treatment.

Before taking Vyzulta (latanoprostene bunod), it is important to be aware of certain warnings and precautions. First and foremost, inform your healthcare provider about any existing medical conditions you may have, especially if you have a history of eye problems, such as uveitis or macular edema. Additionally, let your doctor know about any medications you are currently taking, including over-the-counter drugs, vitamins, and herbal supplements. Certain medications, such as prostaglandins and prostaglandin analogs, may interact with Vyzulta and cause adverse effects. If you are pregnant, planning to become pregnant, or breastfeeding, consult your doctor before using Vyzulta. It is essential to weigh the potential risks and benefits, as the effects of this medication on unborn babies and infants are not fully understood. While using Vyzulta, be cautious about driving or operating machinery, as it may cause blurred vision or other visual disturbances. Wait until your vision clears before engaging in such activities. If you experience any eye-related side effects, like eye pain, redness, swelling, or changes in vision, contact your doctor immediately. Regular eye exams are also recommended to monitor your eye pressure and overall eye health. Remember, this information is only a brief overview. Always follow your healthcare provider's instructions and read the medication guide provided with Vyzulta for a complete understanding of its warnings and precautions.

Vyzulta (latanoprostene bunod) is a medication primarily used to lower eye pressure in individuals with open-angle glaucoma or ocular hypertension. While it is generally well-tolerated, like any medication, Vyzulta has the potential to cause certain side effects. These may include: 1. Eye Irritation: Some individuals may experience mild to moderate eye irritation, such as itching, burning, or redness. 2. Eye Discomfort: Vyzulta may cause a sensation of something being in the eye or a general discomfort. 3. Blurred Vision: Blurred vision can occur temporarily after applying the medication. It should subside on its own, but if it persists or worsens, it's important to contact your healthcare provider. 4. Eye Redness: Vyzulta may cause temporary eye redness, which should resolve over time. 5. Changes in Eyelashes: In some cases, the medication may lead to changes in the appearance or growth pattern of the eyelashes, including increased length, thickness, or darkness. 6. Darkening of the Iris: Long-term use of Vyzulta may result in a gradual, irreversible darkening of the color of the iris (the colored part of the eye). It's important to remember that not everyone will experience these side effects, and they are typically mild and temporary. If you have any concerns or if these side effects become severe or persistent, it is advisable to consult with your eye doctor or healthcare provider for further guidance.

Vyzulta (latanoprostene bunod) is an eye drop medication prescribed to lower intraocular pressure (IOP) in patients diagnosed with open-angle glaucoma or ocular hypertension. It contains a combination of two active ingredients, latanoprost and butanediol mononitrate. Latanoprost is a prostaglandin analogue that helps to decrease IOP by increasing the outflow of fluid from the eye. By stimulating the prostaglandin receptors in the eye, it improves the drainage of aqueous humor, reducing pressure within the eye. Butanediol mononitrate, a nitric oxide (NO)-donating moiety, is unique to Vyzulta. It is converted to nitric oxide in the eye, which then acts to relax the blood vessels in the eye's tissues. This vasodilation helps in further reducing intraocular pressure. Together, these two ingredients work synergistically to lower IOP and protect the optic nerve, which is crucial in managing glaucoma and preventing vision loss. It is important to follow the prescribed dosage and administration instructions provided by your healthcare professional. As with any medication, Vyzulta may have potential side effects or contraindications, so it's essential to consult your doctor for personalized advice and monitoring.

Vyzulta (latanoprostene bunod) is a medication used to lower intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Proper storage of Vyzulta is essential to maintain its effectiveness and ensure patient safety. Vyzulta is supplied as a liquid solution in a multi-dose container. It should be stored at room temperature, between 68°F and 77°F (20°C to 25°C). Protect the bottle from light by keeping it in its original packaging until ready to use. Once opened, the product can be used for up to 8 weeks. It is important to follow the manufacturer's instructions regarding the expiration date and discard any unused medication after the specified time frame. Do not use Vyzulta if it has expired or if there are any visible signs of contamination or damage to the container. Always keep Vyzulta out of reach of children and pets to prevent accidental ingestion. If you have any concerns about the storage or handling of Vyzulta, it is best to consult with your healthcare provider or pharmacist for further guidance.